PANK4 and glioblastoma: To further explore the contribution of PANK4 to TMZ resistance, we performed a comprehensive proteomic characterization of TMZ‐resistant GBM cells using a quantitative Tandem Mass Tagging (TMT)‐based proteomic approach (Table S3, Supporting Information), as summarized in Figure7A.